Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.

Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN.

Appl Health Econ Health Policy. 2013 Aug;11(4):407-13. doi: 10.1007/s40258-013-0038-9.

PMID:
23700254
[PubMed - indexed for MEDLINE]
2.

The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.

Suehs BT, Davis CD, Alvir J, van Amerongen D, Pharmd NC, Joshi AV, Faison WE, Shah SN.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):384-92. doi: 10.1177/1533317513488911. Epub 2013 May 17.

PMID:
23687180
[PubMed - indexed for MEDLINE]
3.

Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.

Zhao Y, Kuo TC, Weir S, Kramer MS, Ash AS.

BMC Health Serv Res. 2008 May 22;8:108. doi: 10.1186/1472-6963-8-108.

PMID:
18498638
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.

Fillit H, Hill JW, Futterman R.

Fam Med. 2002 Jul-Aug;34(7):528-35.

PMID:
12144008
[PubMed - indexed for MEDLINE]
5.

Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.

Khanna R, Madhavan SS, Bhanegaonkar A, Remick SC.

J Womens Health (Larchmt). 2011 May;20(5):739-47. doi: 10.1089/jwh.2010.2298. Epub 2011 Mar 21.

PMID:
21417935
[PubMed - indexed for MEDLINE]
7.

Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Insinga RP, Itzler RF, Pellissier JM.

Pharmacoeconomics. 2007;25(2):155-69.

PMID:
17249857
[PubMed - indexed for MEDLINE]
8.

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.

Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032.

PMID:
20110008
[PubMed - indexed for MEDLINE]
9.

Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison.

Leibson C, Owens T, O'Brien P, Waring S, Tangalos E, Hanson V, Plevak M, Kokmen E.

J Am Geriatr Soc. 1999 Jul;47(7):864-9.

PMID:
10404933
[PubMed - indexed for MEDLINE]
10.

The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients.

Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J.

Alzheimer Dis Assoc Disord. 2000 Jul-Sep;14(3):151-9.

PMID:
10994656
[PubMed - indexed for MEDLINE]
11.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
[PubMed - indexed for MEDLINE]
12.

Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.

Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H.

Neurology. 2002 Jan 8;58(1):62-70.

PMID:
11781407
[PubMed - indexed for MEDLINE]
13.

Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.

Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Puenpatom RA, Ben-Joseph RH, Summers KH.

J Med Econ. 2010;13(3):482-91. doi: 10.3111/13696998.2010.506176.

PMID:
20684669
[PubMed - indexed for MEDLINE]
14.

The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies.

Murman DL, Kuo SB, Powell MC, Colenda CC.

Neurology. 2003 Oct 14;61(7):944-9.

PMID:
14557565
[PubMed - indexed for MEDLINE]
15.

Asthma-related healthcare services utilization by African-Americans enrolled in West Virginia Medicaid.

Pawar V, Smith MJ.

Respir Med. 2006 Sep;100(9):1579-87. Epub 2006 Feb 21.

PMID:
16495039
[PubMed - indexed for MEDLINE]
Free Article
16.

Health care service utilization among patients with chronic rhinosinusitis: a population-based study.

Chung SD, Hung SH, Lin HC, Lin CC.

Laryngoscope. 2014 Jun;124(6):1285-9. doi: 10.1002/lary.24500. Epub 2013 Dec 10.

PMID:
24338913
[PubMed - indexed for MEDLINE]
17.

Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.

Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.

Ann Pharmacother. 2007 Nov;41(11):1761-9. Epub 2007 Sep 25.

PMID:
17895328
[PubMed - indexed for MEDLINE]
18.

Direct and indirect costs associated with Dupuytren's contracture.

Macaulay D, Ivanova J, Birnbaum H, Sorg R, Skodny P.

J Med Econ. 2012;15(4):664-71. doi: 10.3111/13696998.2012.670678. Epub 2012 Mar 21.

PMID:
22369346
[PubMed - indexed for MEDLINE]
19.

Implications of comorbidity on costs for patients with Alzheimer disease.

Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS.

Med Care. 2008 Aug;46(8):839-46. doi: 10.1097/MLR.0b013e318178940b.

PMID:
18665064
[PubMed - indexed for MEDLINE]
20.

Alzheimer's disease or other dementia and medical care utilization.

Eaker ED, Mickel SF, Chyou PH, Mueller-Rizner NJ, Slusser JP.

Ann Epidemiol. 2002 Jan;12(1):39-45.

PMID:
11750239
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk